USPTO serial 79134889
BRINTELLIX VORTIOXETINE
Reviewed by CopyMark Law Group
Reg. 4642921Status 404
- Filing date
- Status date
- Registration date
- Nov 25, 2014
- Examiner
- JAGANNATHAN, SIDDHARTH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BRINTELLIX VORTIOXETINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
DK-2500 Valby, DK
DK-2500 Valby, DK
DK-2500 Valby, DK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Claudia A. Smith
Claudia A. Smith White & Case LLP1155 Avenue of the AmericasPatent and Trademark DepartmentNew York, NY 10036Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system to treat or prevent disorders and diseases in or affecting the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcoholism and addiction; preparations, substances, reagents and agents for diagnostic and medical purposes; all the foregoing containing in whole or substantial part vortioxetine | SECTION 70 - CANCELLED | — |
| 009 | Scientific apparatus and instruments, namely, magnetic, electronic and optical data carriers containing information and data in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; pre-recorded audio cassettes, pre-recorded video cassettes, and electronic and digital media featuring information and data in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material, in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; recorded computer software, namely, software for searching, storing, cataloging, and indexing medical and pharmaceutical information, indexing education and sales activities, and for enabling web-based access to websites, enabling database integration, and enabling web searching of websites, intranet and Internet; software that provides web-based access to applications and services through a web operating system or portal interface, software to provide web-based electronic storage and display of digital information in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention in the form of sounds, noises, images, graphics, animated graphics, texts, movies, and databases; data processing equipment and computers; downloadable application software for downloading information on the use of pharmaceutical products and on diseases and disorders of the central nervous system and the treatment thereof; downloadable software for games which provide information related to diseases and disorders of the central nervous system and the treatment thereof; and downloadable mobile applications for transmitting, sharing, receiving, downloading, displaying and transferring content, text, visual works, audio works, audiovisual works, literary works, data, files, documents and electronic works via portable and handheld electronic devices and computers in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention | SECTION 70 - CANCELLED | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments; suture materials; medical apparatus and instruments for diagnostic purposes, namely, apparatus for medical diagnostic testing for diseases and disorders of the central nervous system; integrated medical examination systems comprising medical instruments, hardware and software for information and information management for use of a web-based physical and psychological examination and assessment of patients and information, guidance and control of medicines | SECTION 70 - CANCELLED | — |
| 041 | Educational and training services, namely, seminars, conferences, symposiums, workshops, courses, classes and lectures in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; educational and training services, namely, seminars, conferences, symposiums, workshops, courses, classes and lectures in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention provided electronically, on-line, via cable or Internet or other electronic media; providing non-downloadable on-line publications, namely, books, reports, brochures, booklets, leaflets, leaflets containing patient information, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; Entertainment services, namely, organizing, arranging, and conducting running, walking, golf, tennis, softball, and cycling events and cultural activities | SECTION 70 - CANCELLED | — |
| 042 | Scientific and technological services, namely, scientific research, analysis and testing in the field of pharmaceuticals and research and design relating thereto; industrial research in the field of pharmaceuticals; design and development of computer hardware and software; providing a website featuring non-downloadable software that allows users to view scientific data and information in the field of research and development, science, clinical tests, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; pharmaceutical research and development; scientific and technological services, namely, scientific research, analysis, and testing in the field of disorders, diseases and prevention; scientific and technological services, namely, scientific research, analysis, and testing in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research; providing medical and clinical testing services for research purposes in the fields of central nervous system research and research on central nervous system related disorders, diseases and pharmaceuticals; providing scientific research information in the fields of central nervous system research and research on central nervous system related disorders, diseases and pharmaceuticals; providing scientific testing in the fields of central nervous system research and research on central nervous system related disorders, diseases and pharmaceuticals; providing medical and medicinal research information in the fields of central nervous system research and research on central nervous system related disorders, diseases and pharmaceuticals | SECTION 70 - CANCELLED | — |
| 044 | Medical services; medical services in the field of psychiatry and psychology; medical advisory and information services concerning medical and pharmaceutical preparations and substances; medical clinical services; medical treatment services; therapeutic treatment services, namely, providing therapeutic services to persons in need of treatment for conditions, disorders or diseases of the central nervous system; healthcare and medical services related to central nervous system disorders, diseases and pharmaceuticals; providing for medical and medicinal information in the field of diagnostic, medicine, medical dose, pharmaceuticals, disorders, diseases, treatments and prevention; all the aforementioned services provided off-line as well as on-line | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BRINTELLIX VORTIOXETINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2020 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 7, 2020 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 25, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 8, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 20, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 20, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 25, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 25, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 9, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 20, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 7, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 5, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 4, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 4, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 4, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 4, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 30, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 30, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 24, 2014 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Apr 24, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 16, 2014 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 5, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 23, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 23, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 21, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jan 8, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 30, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 10, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 9, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 9, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 7, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 6, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 3, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 29, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |